Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
It is known that lncRNA
PLAC2
can inhibit glioma. This study explored the function of
PLAC2
in hepatocellular carcinoma (HCC). Our data showed that
PLAC2
expression in HCC was not affect by HCV and HBV infection, while
PLAC2
levels were significantly lower in HCC tissues comparing to non-cancer tissues. Low
PLAC2
levels in HCC tissues were associated with low overall 5-year survival rate.
P53
mRNA was also downregulated in HCC and positively correlated with
PLAC2
.
PLAC2
overexpression caused upregulated
p53
and increase cancer cell apoptosis.
P53
overexpression failed to affect
PLAC2
. In addition,
p53
silencing reduced the effects of
PLAC2
overexpression. Therefore,
PLAC2
upregulated
p53
to mediate cancer cell apoptosis.
...
PMID:LncRNA PLAC2 upregulates p53 to induce hepatocellular carcinoma cell apoptosis. 3123 63